ClinicalTrials.gov
public full text
Public Domain
Different Vitamin D Preparations & FGF23 in Humans
Fibroblast growth factor 23 (FGF23) is a new hormone which controls phosphate and vitamin D levels in humans. Excess FGF23 is associated with an increased risk of death in patients with chronic kidney disease. In this study the investigators are investigating the effects of different forms of vitamin D on FGF23 levels in the blood in order to increase our understanding of how this important hormone works.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Vitamin D Deficiency in Adolescent Girls#841092
- The Effects of Dietary Phosphate Intake on Calciotropic Hormones and FGF23.#874912
- Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts#837163
- Study of the Impact of Phosphate Supplementation on FGF23 Concentrations in Patients With Hypophosphatemia#993655
- The Impact of Vitamin D Supplementation on Pregnant Women With the Risk of GDM#1104233
Record · ID 1228432
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive